| Literature DB >> 25669433 |
Maria Grazia Biferi1, Carmine Nicoletti2, Germana Falcone3, Eleonora M R Puggioni1, Nunzia Passaro1, Alessia Mazzola1, Deborah Pajalunga1, Germana Zaccagnini4, Emanuele Rizzuto5, Alberto Auricchio6, Lorena Zentilin7, Gabriele De Luca8, Mauro Giacca7, Fabio Martelli4, Antonio Musio9, Antonio Musarò10, Marco Crescenzi11.
Abstract
Although in the last decades the molecular underpinnings of the cell cycle have been unraveled, the acquired knowledge has been rarely translated into practical applications. Here, we investigate the feasibility and safety of triggering proliferation in vivo by temporary suppression of the cyclin-dependent kinase inhibitor, p21. Adeno-associated virus (AAV)-mediated, acute knockdown of p21 in intact skeletal muscles elicited proliferation of multiple, otherwise quiescent cell types, notably including satellite cells. Compared with controls, p21-suppressed muscles exhibited a striking two- to threefold expansion in cellularity and increased fiber numbers by 10 days post-transduction, with no detectable inflammation. These changes partially persisted for at least 60 days, indicating that the muscles had undergone lasting modifications. Furthermore, morphological hyperplasia was accompanied by 20% increases in maximum strength and resistance to fatigue. To assess the safety of transiently suppressing p21, cells subjected to p21 knockdown in vitro were analyzed for γ-H2AX accumulation, DNA fragmentation, cytogenetic abnormalities, ploidy, and mutations. Moreover, the differentiation competence of p21-suppressed myoblasts was investigated. These assays confirmed that transient suppression of p21 causes no genetic damage and does not impair differentiation. Our results establish the basis for further exploring the manipulation of the cell cycle as a strategy in regenerative medicine.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25669433 PMCID: PMC4424006 DOI: 10.1038/mt.2015.27
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454